🟢 Veraxa Biotech is trading 6.36% up in after-hours trading

Veraxa Biotech is trading at $1.17, up 6.36%, with the move’s cause unconfirmed.

• The company’s investor-relations page lists October 13 as its latest release, covering BiTAC-ADC proof-of-concept data.
• That research announcement predates the after-hours move, and available information does not establish it as the cause. Major indexes were mixed in the supplied market context, which does not clearly explain the gain.